You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mental Health of Patients With Multiple Myeloma

Not yet recruiting
  • Psychological Distress
  • +2 more
    • (no location specified)
    Nov 16, 2022

    Multiple Myeloma Trial in Boston (Health Through Activity)

    Not yet recruiting
    • Multiple Myeloma
    • Health Through Activity
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jan 17, 2023

    Non-invasive MRD Assessment in Multiple Myeloma

    Recruiting
    • Myeloma
    • MRD Assessment
    • New York, New York
      New York Presbyterian Hospital/Columbia University Irving Medica
    Nov 15, 2022

    Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 15, 2022

    Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in San Francisco (Pembrolizumab)

    Not yet recruiting
    • Multiple Myeloma
    • +4 more
    • Pembrolizumab
    • San Francisco, California
      University of California, San Francisco
    Mar 23, 2022

    Multiple Myeloma, Adapted Physical Activity, Chronic Pain Trial (adapted physical activity)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • adapted physical activity
    • (no location specified)
    Sep 19, 2022

    Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in New York (MCARH125, MCARH109)

    Recruiting
    • Multiple Myeloma
    • +2 more
    • MCARH125
    • MCARH109
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jun 20, 2022

    Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) Trial in Boston (Prolonged Fasting Intervention,

    Not yet recruiting
    • Cancer Prevention
    • +5 more
    • Prolonged Fasting Intervention
    • EDUCATION CONTROL
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Dec 28, 2022

    Multiple Myeloma Trial in Houston (Belantamab mafodotin)

    Not yet recruiting
    • Multiple Myeloma
    • Belantamab mafodotin
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 31, 2022

    Based on PRO Data Reported ThroughMHealth App Solution in

    Completed
    • Multiple Myeloma
    • mHealth app
    • Odense, Denmark
      Odense University Hospital
    Feb 10, 2023

    Multiple Myeloma Trial in New York (Circadian Effective Lighting, Circadian Ineffective Lightning (CIL))

    Recruiting
    • Multiple Myeloma
    • Circadian Effective Lighting
    • Circadian Ineffective Lightning (CIL)
    • New York, New York
    • +1 more
    Feb 10, 2023

    Multiple Myeloma Trial in Beijing, Qingdao (SPD:Selinexor Oral Tablet, Pomalidomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • SPD：Selinexor Oral Tablet, Pomalidomide, Dexamethasone
    • Beijing, Beijing, China
    • +1 more
    Jul 26, 2022

    Relapsed or Refractory Multiple Myeloma Trial in Dummy (Teclistamab)

    Available
    • Relapsed or Refractory Multiple Myeloma
    • Dummy, France
    • +2 more
    Aug 10, 2022

    Multiple Myeloma Trial in Rochester (Daratumumab, Lenalidomide, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Rochester, New York
      University of Rochester Medical Center
    Jul 8, 2022

    Multiple Myeloma Trial (Continued treatment adapted to the response)

    Completed
    • Multiple Myeloma
    • Continued treatment adapted to the response
    • (no location specified)
    Jan 14, 2023

    Multiple Myeloma Trial in Houston (Isatuximab, lenalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2023

    Multiple Myeloma Trial in Hangzhou (BCMA CAR-T cells injection)

    Recruiting
    • Multiple Myeloma
    • BCMA CAR-T cells injection
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Feb 13, 2023

    Multiple Myeloma Trial in Saint Petersburg (Melphalan, Nivolumab, Autologous Stem Cell Transplantation)

    Recruiting
    • Multiple Myeloma
    • Saint Petersburg, Russian Federation
      Boris V Afanasyev, MD, Prof.
    Apr 4, 2022

    Carfilzomib in Patients With Multiple Myeloma

    Recruiting
    • Multiple Myeloma
    • Odense, Denmark
      Odense University Hospital
    Dec 20, 2022

    Multiple Myeloma Trial in Shanghai (GC012F injection)

    Recruiting
    • Multiple Myeloma
    • GC012F injection
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Jul 23, 2022

    Relapsed/Refractory Multiple Myeloma Trial (AMG 701)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • AMG 701
    • (no location specified)
    Jun 6, 2022

    The Aim is to Identify Recurrent Genomic Mutations and/or

    Not yet recruiting
    • Multiple Myeloma
    • DNA sequencing
    • Pierre Benite, France
      Hospices Civils de Lyon
    Apr 12, 2022

    Questionnaire and Tissue Banking For Multiple Myeloma,

    Active, not recruiting
    • Multiple Myeloma
    • +3 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 15, 2022

      Multiple Myeloma Trial in New York (Iberdomide, Elotuzumab, Dexamethasone)

      Recruiting
      • Multiple Myeloma
      • New York, New York
        Icahn School of Medicine
      Jan 20, 2023

      Multiple Myeloma, Stem Cell Transplant Complications Trial in Boston (PARE, Waitlist Control Group)

      Not yet recruiting
      • Multiple Myeloma
      • Stem Cell Transplant Complications
      • PARE
      • Waitlist Control Group
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jan 30, 2023